MCW

The company plans to use Thermo Fisher Scientific's newly launched PharmacoScan array-based platform for its testing.

The study will create a new rat model of disease to find genes that could inhibit tumor progression.

The database has received a total of $35 million in funding, and in 2014 more than 180,000 scientists accessed it for their research.

Photo of Nathan Ledeboer

Point-of-care testing, automation, and panelization of nucleic acid amplification testing are the future of the clinical lab ― and will likely change how labs and clinicians relate.

NEW YORK (GenomeWeb News) – The Medical College of Wisconsin said on Wednesday that it has been awarded a four-year, $1.5 million grant from the National Heart, Lung, and Blood Institute to investigate genetic variants that may contribute to end-stage renal disease (ESRD).

Researchers from Boston Children's Hospital, working with the Medical College of Wisconsin and the Children's Hospital of Wisconsin Research Institute, are planning to preemptively test 1,000 children in several different clinical care areas using a broad PGx genotyping approach

NEW YORK (GenomeWeb News) – A team at the Medical College of Wisconsin will use a five-year, $8.7 million grant from the National Heart, Lung, and Blood Institute to create new genetically modified rat models for studying genetics of human diseases, MCW said today.

NEW YORK (GenomeWeb News) – Three institutions – Boston Children's Hospital, the Medical College of Wisconsin, and the Children's Hospital of Wisconsin Research Institute – have launched a study to assess how genetics can influence pediatric patients' ability to respond to various drugs.

Molecular diagnostics firm Nanosphere believes the results of a new multicenter study that assessed the performance of its Verigene Gram-Positive Blood Culture Test could lead to broader clinical adoption, according to a company spokesperson.

The Medical College of Wisconsin's Human and Molecular Genetics Center recently started offering clinical whole-genome and whole-exome sequencing tests to external physicians, after piloting diagnostic genome sequencing in house for several years.

Pages

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

In Nature this week: a Danish reference genome, and more.